Celltrion Launches U.S. Phase 4 Trial of High-Dose Zymfentra 나은경 2026.09.15 오전 10:44 Bio&Pharma Stocks: BL Pharmtech, Celltrion and Amicogen on the Rise 임정요 2025.02.27 오전 08:33 Trump Eyes Drug Tariffs-What It Means for K-Bio 김진수 2025.05.07 오전 10:16 Celltrion’s Zymfentra Prescriptions Surge in U.S., Hitting Record Monthly High 송영두 2026.03.18 오전 08:46 Remsima SC Captures 22% of European Market, 5 Fold Growth in 4 Years 송영두 2025.05.28 오전 10:01 Celltrion’s Remsima Tops KRW 1 Trillion in Annual Sales for Second Straight Year 김새미 2026.02.10 오전 10:05 Celltrion Posts Record Q2 Results, Accelerates Global Pharma Ambitions 나은경 2025.07.24 오전 10:58 Celltrion Unfazed by U.S. Price Cuts, Tariffs Zymfentra Drag Tied to Insurance 송영두 2025.05.15 오후 03:23 셀트리온, 첫 미국 신약 ‘짐펜트라’ 출시 석지헌 2024.03.18 오전 08:43 Celltrion Posts Record-High Q2 Earnings with 235% Surge in Operating Profit 송영두 2025.07.21 오전 10:03 더 보기 로딩중..
Zymfentra
Zymfentra
